I’m an active member of the Cytokine Working Group that develops biologic therapies for patients with melanoma and kidney cancer. I’m also a member of the National Comprehensive Cancer Network (NCCN) committees on non-prostate genitourinary and non-melanoma skin cancer.
In addition, I’m actively involved with the Melanoma Research Foundation’s Community United for Research and Education of Ocular Melanoma (CURE OM) and the International Rare Cancers Initiative (IRCI) ocular melanoma group.
Michigan State University
7/1/1981 - 6/30/1984
Specialties and conditions I treat
- Medical Oncology
- Skin Cancers
- Carcinoma, Renal Cell
- Eye Cancers
- Eye Cancers
Locations where I practice
The James at Martha Morehouse Medical Plaza
More about my work
Wayne State University Hospitals
7/1/1984 - 6/30/1987
American Board of Internal Medicine
American Board of Internal Medicine (Subspecialty: Medicine Oncology)
News about me
At The Ohio State University Wexner Medical Center, we support a faculty member’s research and consulting in collaboration with medical device, research and/or drug companies because a faculty member’s expertise can guide important advancements in the practice of medicine and improve patient care. In order to provide effective management of these relationships, the University requires annual disclosures from all faculty members with external interests related to their University responsibilities.
As of 03/25/2016, Dr. Olencki has reported no financial relationships with medical device, research and/or drug companies.